Lucy graduated as a physician assistant, earned an MBA, and worked for seven years in sales and sales training with Bristol-Myers Squibb prior to serving as the Director of the Division of Drug Marketing, Advertising, and Communications and the Office of Training and Communications at FDA. For the last 18 years she has consulted with numerous pharmaceutical companies on promotional regulations/strategy, drug development and regulatory strategy, health policy, and has enjoyed training many professionals on advertising/promotional regulations.

Dwight Bowen received his Pharm.D. degree from Philadelphia College of Pharmacy in 2011. He then accepted a position with the Eli Lilly and Company Visiting Scientist Fellowship. His fellowship year was spent in the regulatory affairs US Advertising and Promotions group. After completing the fellowship, Dwight remained at Lilly in the ad/promo group for about 6 years and served as the regulatory reviewer for multiple compounds across the company's portfolio as well as some commercialization alliances. Currently he works at Shire and is a director within the ad/promo group.

Elizabeth (Liz) is responsible for the creation and implementation of a strategically driven compliance program for Spark Therapeutics, Inc. Prior to joining Spark in April of 2015, Liz was Senior Vice President, Chief Compliance Officer at Auxilium Pharmaceuticals, Inc. from 2012 to 2015. Auxilium was acquired by Endo Pharmaceuticals, Inc. in early 2015. Liz received her J.D. from Rutgers School of Law, where she was a Patricia Harris Fellow, and her B.A. in International Politics and Foreign Service from Pennsylvania State University, State College, PA.

Jess Amchin, MD, JD is President of Jess Amchin Consulting, LLC, a firm providing medical and business consultation and training services for pharmaceutical, biotechnology, and other companies in a wide range of therapeutic areas. He has worked extensively in both clinical research and medical affairs. Among his various assignments as a consultant, Dr. Amchin has served as a medical monitor for clinical research trials and as a medical reviewer on advertising and promotional review committees.